Histologic features in the urinary bladder wall affected from neurogenic overactivity -: A comparison of inflammation, oedema and fibrosis with and without injection of botulinum toxin type A

被引:124
作者
Comperat, Eva [1 ]
Reitz, Andre
Delcourt, Annick
Capron, Frederique
Denys, Pierre
Chartier-Kastler, Emmanuel
机构
[1] Univ Paris 06, Hop La Pitie Salpetriere, Serv Anat Pathol, F-75013 Paris, France
[2] Univ Paris 06, Hop La Pitie Salpetriere, Urol Serv, F-75013 Paris, France
[3] Univ Paris Ile France Ouest, Hop Raymond Poincare, AP, Serv Med Phys & Readaptat, Paris, France
关键词
neurogenic bladder; botulinum toxin; inflammation; fibrosis; oedema; SPINAL-CORD-INJURY; STRUCTURAL BASIS; DETRUSOR HYPERREFLEXIA; DYSFUNCTION; INCONTINENCE; SUCCESS; MUSCLE;
D O I
10.1016/j.eururo.2006.01.025
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To study histological features and morphological differences in bladder wall specimen from patients with and without botulinum toxin A injections and to compare those issues in responders and non-responders to the toxin therapy. Material and methods: Bladder wall specimen obtained from cystectomy in 45 patients with neurogenic overactive bladders with and without injection of botulinum toxin A into the detrusor muscle for treatment of neurogenic incontinence were evaluated concerning the histological criteria inflammation, oedema and fibrosis of the bladder wall. Results: Bladder wall specimen obtained from patients suffering from neurogenic detrusor overactivity showed important histological alterations. Generally, inflammatory infiltration, oedema and fibrosis of the bladder wall were frequently observed. When comparing specimen from patients who had received botulinum toxin injection to those from patients who had not, there was no difference concerning inflammation and oedema. However, patients who had received botulinum toxin injection showed significantly less fibrosis of the bladder wall than those who had not received the toxin injection (p < 0.00073). When comparing specimen from responders and non-responders to the botulinum. toxin therapy there was no difference in inflammation. Although not significant, a trend was observed that responder to the toxin therapy had less fibrosis and oedema of the bladder wall than non-responder. Conclusion: in our study injection of botulinum toxin into the detrusor muscle did not lead to increased fibrotic activity within the bladder wall, on the contrary patients with previous botulinum toxin injection revealed significant less fibrosis than patients without toxin injection. (c) 2006 European Association of Urology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1058 / 1064
页数:7
相关论文
共 19 条
[1]   Factors involved in the success of antimuscarinic treatment [J].
Abrams, P ;
Larsson, G ;
Chapple, C ;
Wein, AJ .
BJU INTERNATIONAL, 1999, 83 :42-47
[2]   Long-term results of augmentation cystoplasty in spinal cord injury patients [J].
Chartier-Kastler, EJ ;
Mongiat-Artus, P ;
Bitker, MO ;
Chancellor, MB ;
Richard, F ;
Denys, P .
SPINAL CORD, 2000, 38 (08) :490-494
[3]   Suppression of bladder hyperreflexia by intravesical resiniferatoxin [J].
Cruz, F ;
Guimaraes, M ;
Silva, C ;
Reis, M .
LANCET, 1997, 350 (9078) :640-641
[4]   STRUCTURAL BASIS OF GERIATRIC VOIDING DYSFUNCTION .4. BLADDER OUTLET OBSTRUCTION [J].
ELBADAWI, A ;
YALLA, SV ;
RESNICK, NM .
JOURNAL OF UROLOGY, 1993, 150 (05) :1681-1695
[5]   INTRAVESICAL CAPSAICIN FOR NEUROGENIC BLADDER DYSFUNCTION [J].
FOWLER, CJ ;
JEWKES, D ;
MCDONALD, WI ;
LYNN, B ;
DEGROAT, WC .
LANCET, 1992, 339 (8803) :1239-1239
[6]   MORPHOLOGICAL AND MORPHOMETRIC STUDIES OF THE HUMAN OBSTRUCTED, TRABECULATED URINARY-BLADDER [J].
GILPIN, SA ;
GOSLING, JA ;
BARNARD, RJ .
BRITISH JOURNAL OF UROLOGY, 1985, 57 (05) :525-529
[7]   Success of repeat detrusor injections of botulinum A toxin in patients with severe neurogenic detrusor overactivity and incontinence [J].
Grosse, J ;
Kramer, G ;
Stöhrer, M .
EUROPEAN UROLOGY, 2005, 47 (05) :653-659
[8]   Lack of ultrastructural detrusor changes following endoscopic injection of Botulinum toxin type A in overactive neurogenic bladder [J].
Haferkamp, A ;
Schurch, B ;
Reitz, A ;
Krengel, U ;
Grosse, J ;
Kramer, G ;
Schumacher, S ;
Bastian, PJ ;
Büttner, R ;
Müller, SC ;
Stöhrer, M .
EUROPEAN UROLOGY, 2004, 46 (06) :784-791
[9]   Structural basis of neurogenic bladder dysfunction.: II.: Myogenic basis of detrusor hyperreflexia [J].
Haferkamp, A ;
Dörsam, J ;
Resnick, NM ;
Yalla, SV ;
Elbadawi, A .
JOURNAL OF UROLOGY, 2003, 169 (02) :547-554
[10]   Structural basis of neurogenic bladder dysfunction.: III.: Intrinsic detrusor innervation [J].
Haferkamp, A ;
Dörsam, J ;
Resnick, NM ;
Yalla, SV ;
Elbadawi, A .
JOURNAL OF UROLOGY, 2003, 169 (02) :555-562